Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression

Cancer

Volumn 79, Issue 2, 1997, Pages 380-389

  Åkervall, Jan A ^a   Michalides, Rob J A M ^b   Mineta, Hiroyuki ^a   Balm, Alfons ^b   Borg, Åke ^a   Dictor, Michael R ^a   Jin, Yuesheng ^a   Loftus, Barbara ^b   Mertens, Fredrik ^a   Wennerberg, Johan P ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

chromosomal abnormality; head and neck; oncogene; prognosis; squamous cell carcinoma

Indexed keywords

CYCLIN D1; DNA;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE AMPLIFICATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0031023529     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.3.CO;2-5     Document Type: Article

References (42)

1. Bailey BJ. Beyond the "new" TNM classification. Arch Otolaryngol Head Neck Surg 1991;117:369-70.
2. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a BCL-1 linked candidate oncogene. Nature 1991;350:512-5.
3. Jiang W, Kahn SM, Zhang Y, Cacace AM, Infante AS, Doi S, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993;8:3447-57.
4. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994;91:709-13.
5. Iniba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992;13:565-74.
6. Xiong Y, Menninger J, Beach D, Ward DC. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992;13:575-84.
7. Motokura T, Keyomarsi K, Kronenberg HM, Arnold A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem 1992;267:20412-5.
8. Arnold A, Kim HG, Gaz RD, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034-40.
9. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A. Rearrangements and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 1991;6:449-53.
10. Akiyama N, Tsuruta H, Sasaki H, et al. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Res 1994;54:377-9.
11. Tsuruta H, Sakamoto H, Onda M, Terada M. Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 1993;196:1529-36.
12. Jiang W, Hahn SM, Tomita N, Zhang Y, Lu S, Weinstein IB. Amplification and expression of human cyclin D gene in esophageal cancer. Cancer Res 1992;52:2980-3.
13. Fantl V, Richards MA, Smith R, et al. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 1990;26:423-9.
14. Lammie GA, Fantl V, Smith R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 1991;6:439-44.
15. Parise O Jr., Janot F, Guerry R, et al. Chromosome 11q13 gene amplifications in head and neck squamous cell carcinomas: relation with lymph node invasion. Int J Oncol 1994;5:309-13.
16. Jares P, Fernandez PL, Campo E, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-7.
17. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. Prad-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994;74:152-8.
18. Muller D, Millon R, Lidereau R, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Oral Oncol Eur J Cancer 1994;30B:113-20.
19. Meredith SD, Levine PA, Burns JA, et al. Chromosome 11q13 amplification in head and neck squamous cell carcinoma: association with poor prognosis. Arch Otolaryngol Head Neck Surg 1995;121:790-4.
20. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of fourty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
21. Jin Y, Mertens F, Mandahl N, et al. Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res 1993;53:2140-6.
22. Van Dyke DL, Worsham M, Benninger MS, et al. Recurrent cytogenetic abnormalities in squamous cell carcinoma of the head and neck region. Genes Chromosomes Cancer 1994;9:192-206.
23. Jin Y, Mertens F, Jin C, et al. Nonrandom chromosome abnormalities in short-term cultured primary squamous cell carcinomas of the head and neck. Cancer Res 1995;55:3204-10.
24. Åkervall J, Jin Y, Wennerberg J, et al. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in squamous cell carcinoma of the head and neck. Cancer 1995;76:453-9.
25. Hermanek P, Sobin L. TNM classification of malignant tumours. 4th edition. Berlin: Springer, 1987.
26. Jin Y, Heim S, Mandahl N, Biörklund A, Wennerberg J, Mitelman F. Multiple apparently unrelated clonal chromosome abnormalities in a squamous cell carcinoma of the tongue. Cancer Genet Cytogenet 1988;32:93-100.
27. Mitelman F, Editor. ISCN: guidelines for cancer cytogenetics [supplement to the International System for Human Cytogenetic Nomenclature]. Basel: Karger, 1991:1-54.
28. Bartokova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56.
29. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 1989;4:1111-6.
30. Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schurring E, Levine PA. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:1238-43.
31. Xu L, Davidson BJ, Murty VVVS, et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma. Int J Cancer 1994;59:383-7.
32. Wang X, Pavelic ZP, Li Y-Q, et al. Amplification and overexpression of the cyclin D1 gene in head and neck squamous cell carcinoma. J Clin Pathol. Mol Pathol 1995;48:M256-259.
33. Gaffey MJ, Iezzoni JC, Meredith SD, et al. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase π gene expression in head and neck squamous cell carcinoma. Hum Pathol 1995;26:1221-6.
34. Schuuring E, Verhoeven E, Mooi WJ, Michalides R. Identification and cloning of two overexpressed genes, U21B31/ PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992;7:355-61.
35. Patel AM, Incognito LS, Schechter GL, Wasilenko WJ, Somers KD. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 1996;12:31-5.
36. Karlseder J, Zeillinger R, Schneeberger C, et al. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 1994;9:42-8.
37. Michalides R, Hageman P, van Tinteren H, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996;73:728-34.
38. Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-7.
39. Jin Y, Higashi K, Mandahl N, et al. Frequent rearrangements of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chromosomes Cancer 1990;2:198-204.
40. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in TD-47D human breast cancer cell cycle progression. Mol Cell Biol 1993;13:3577-87.
41. Ishitoya J, Toriyama M, Oguchi N, et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 1989;59:559-62.
42. Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexö E. A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 1995;72:1487-93.